display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - HER2-positivebreast cancer - HR positive
es-BC - HER2 positive - (neo)adjuvant (NA)la/mBC - HR positivela/mBC - HR positive - L2 - all population
chemotherapy
non platinum-based chemotherapy
microtubul inhibitor
eribulin NCT03051659
taxanes
paclitaxel
paclitaxel followed by doxorubicin plus cyclophosphamide IMpassion-050 IMpassion-050 IMpassion-050
pegylated liposomal doxorubicin and cyclophosphamide ICON

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons